Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-8,257
Closed -$332K 743
2022
Q4
$332K Sell
8,257
-2,199
-21% -$90.6K ﹤0.01% 554
2022
Q3
$458K Buy
10,456
+2,982
+40% +$142K ﹤0.01% 575
2022
Q2
$265K Sell
7,474
-16,168
-68% -$599K ﹤0.01% 553
2022
Q1
$962K Buy
23,642
+4,976
+27% +$299K ﹤0.01% 504
2021
Q4
$1.74M Buy
18,666
+11,855
+174% +$1.23M 0.01% 354
2021
Q3
$759K Buy
6,811
+3,531
+108% +$405K ﹤0.01% 453
2021
Q2
$372K Sell
3,280
-11,522
-78% -$1.18M ﹤0.01% 511
2021
Q1
$1.5M Sell
14,802
-3,879
-21% -$425K 0.01% 324
2020
Q4
$1.86M Buy
18,681
+10,256
+122% +$857K 0.01% 297
2020
Q3
$609K Buy
+8,425
New +$479K ﹤0.01% 332

Other funds holding NTRA

Brookfield Corp's NTRA Position: Q1 2023 in Review

Brookfield Corp sold out of Natera (NTRA) in Q1 2023, closing a stake of 8,257 shares — an estimated $332K sold.

Brookfield Corp first reported a position in NTRA in Q3 2020 and held it in 10 quarters. The position peaked at $1.86M in Q4 2020. 327 funds tracked by Wall St. Rank hold NTRA as of Q1 2023.

  • Brookfield Corp reported no remaining Natera position as of Q1 2023 after selling out during the quarter.
  • Brookfield Corp sold 8,257 Natera shares in Q1 2023, an estimated $332K.
  • Brookfield Corp first reported a position in Natera in Q3 2020 and held it in 10 quarters.
  • Brookfield Corp's Natera position peaked at $1.86M in Q4 2020.
  • 327 funds tracked by Wall St. Rank held Natera as of Q1 2023.

Based on Brookfield Corp's 13F filing for Q1 2023, filed 15 May 2023.